06/18/2026
Lipid management remains a cornerstone of secondary prevention in , with increasingly strong evidence supporting its central role across all vascular territories, including coronary, cerebrovascular, and peripheral arterial beds.
The 2024 ACC/AHA/Multisociety Guideline for the Management of Lower Extremity and the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia collectively represent a major paradigm shift toward more aggressive, unified, and prevention-driven lipid-lowering strategies. From a vascular medicine perspective, where clinicians routinely manage patients with systemic atherosclerosis, these updates are transformative.
Read more: https://bit.ly/4guCDMK